Mysterious Akkermansia muciniphila. What do we know about it? A review

"Microbes and humans" is a topic that has been continuously studied over the past decade. Numerous recent studies show that quantitative and qualitative changes in the composition of the gastrointestinal tract microbiota have direct and indirect effects on metabolic changes in the host. Many countries are researching the microbiome and opportunities to influence health through environmental modification and introducing a probiotic, a metabiotic, or a synbiotic into the body. Considerable attention is paid to metabolic disorders and obesity, as these are issues that are becoming a progressive global epidemic. More than 2 billion people are overweight and obese, and many experts continue to look for promising methods to combat it. A special group of high risk for obesity is children. Statistics show a steady upward trend of obesity in children. Over the past 10 years, this trend has shown a rapid pace: from 6.7%, according to 2010, to 9.1% by 2020. In this context, Akkermansia muciniphila attracts special attention among all bacteria inhabiting the gastrointestinal tract due to its potential to treat insulin resistance, obesity, and diabetes mellitus. This article reviews new research on the A. muciniphila effects on the host and ways to correct metabolism using probiotics.

[1]  Yating Liu,et al.  Akkermansia muciniphila as a Next-Generation Probiotic in Modulating Human Metabolic Homeostasis and Disease Progression: A Role Mediated by Gut–Liver–Brain Axes? , 2023, International journal of molecular sciences.

[2]  C. Knauf,et al.  A newly identified protein from Akkermansia muciniphila stimulates GLP-1 secretion. , 2021, Cell metabolism.

[3]  Dohyun Han,et al.  Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice , 2021, Nature Microbiology.

[4]  Huiping Yuan,et al.  Gut bacteria Akkermansia is associated with reduced risk of obesity: evidence from the American Gut Project , 2020, Nutrition & Metabolism.

[5]  Zhenghong Li,et al.  Comparison of gut microbiota in exclusively breast-fed and formula-fed babies: a study of 91 term infants , 2020, Scientific Reports.

[6]  W. D. de Vos,et al.  Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro , 2020, Scientific Reports.

[7]  K. Tobe,et al.  Anti-obesity effect of a hop-derived prenylflavonoid isoxanthohumol in a high-fat diet-induced obese mouse model , 2020, Bioscience of microbiota, food and health.

[8]  W. D. de Vos,et al.  Pasteurized Akkermansia muciniphila increases whole-body energy expenditure and fecal energy excretion in diet-induced obese mice , 2020, Gut microbes.

[9]  Ning Wang,et al.  Function of Akkermansia muciniphila in Obesity: Interactions With Lipid Metabolism, Immune Response and Gut Systems , 2020, Frontiers in Microbiology.

[10]  G. Núñez,et al.  Host–microbiota interactions in inflammatory bowel disease , 2020, Nature Reviews Immunology.

[11]  G. Shulman,et al.  Regulation of adipose tissue inflammation by interleukin 6 , 2020, Proceedings of the National Academy of Sciences.

[12]  J. Blanco-Rivero,et al.  Beneficial Effect of a Multistrain Synbiotic Prodefen® Plus on the Systemic and Vascular Alterations Associated with Metabolic Syndrome in Rats: The Role of the Neuronal Nitric Oxide Synthase and Protein Kinase A , 2020, Nutrients.

[13]  T. Weir,et al.  Weight Gain, Adiposity and Intestinal Function in Ovariectomized , 2019 .

[14]  J. Raes,et al.  Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study , 2019, Nature Medicine.

[15]  Ting Zhang,et al.  Akkermansia muciniphila is a promising probiotic , 2019, Microbial biotechnology.

[16]  S. Duncan,et al.  Alterations in the Abundance and Co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the Colonic Mucosa of Inflammatory Bowel Disease Subjects , 2018, Front. Cell. Infect. Microbiol..

[17]  W. D. de Vos,et al.  Akkermansia muciniphila in the Human Gastrointestinal Tract: When, Where, and How? , 2018, Microorganisms.

[18]  Hao Jiang,et al.  Dietary Polysaccharide from Enteromorpha Clathrata Modulates Gut Microbiota and Promotes the Growth of Akkermansia muciniphila, Bifidobacterium spp. and Lactobacillus spp. , 2018, Marine drugs.

[19]  W. Au,et al.  Involvement of gut microbiome in human health and disease: brief overview, knowledge gaps and research opportunities , 2018, Gut Pathogens.

[20]  W. D. de Vos,et al.  Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice , 2017, Gut.

[21]  W. D. de Vos,et al.  Action and function of Akkermansia muciniphila in microbiome ecology, health and disease. , 2017, Best practice & research. Clinical gastroenterology.

[22]  Yan Wang,et al.  Myosin IIA-related Actomyosin Contractility Mediates Oxidative Stress-induced Neuronal Apoptosis , 2017, Front. Mol. Neurosci..

[23]  Danielle G. Lemay,et al.  The Fecal Microbial Community of Breast-fed Infants from Armenia and Georgia , 2017, Scientific Reports.

[24]  W. D. de Vos,et al.  A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice , 2016, Nature Medicine.

[25]  Jacobo de la Cuesta-Zuluaga,et al.  Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid–Producing Microbiota in the Gut , 2016, Diabetes Care.

[26]  T. Shoji,et al.  Non-absorbable apple procyanidins prevent obesity associated with gut microbial and metabolomic changes , 2016, Scientific Reports.

[27]  R. Lentle,et al.  The Characteristics and Function of Bacterial Lipopolysaccharides and Their Endotoxic Potential in Humans , 2016, International reviews of immunology.

[28]  E. Levy,et al.  Triggering Akkermansia with dietary polyphenols: A new weapon to combat the metabolic syndrome? , 2016, Gut microbes.

[29]  E. Jirillo,et al.  Nutritional Keys for Intestinal Barrier Modulation , 2015, Front. Immunol..

[30]  R. Gomis,et al.  Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice , 2015, Scientific Reports.

[31]  F. Levenez,et al.  Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology , 2015, Gut.

[32]  F. Milagro,et al.  Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats. , 2015, The Journal of nutritional biochemistry.

[33]  L. O’Driscoll,et al.  Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies , 2015, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[34]  K. Kalanetra,et al.  Stool Microbiota and Vaccine Responses of Infants , 2014, Pediatrics.

[35]  Patrice D Cani,et al.  Gut microbiota, enteroendocrine functions and metabolism. , 2013, Current opinion in pharmacology.

[36]  Liping Zhao.  The gut microbiota and obesity: from correlation to causality , 2013, Nature Reviews Microbiology.

[37]  Na-Ri Shin,et al.  An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice , 2013, Gut.

[38]  I. van Seuningen,et al.  Membrane-bound mucin modular domains: from structure to function. , 2013, Biochimie.

[39]  Lucie Geurts,et al.  Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity , 2013, Proceedings of the National Academy of Sciences.

[40]  W. D. de Vos,et al.  Glycobiome: bacteria and mucus at the epithelial interface. , 2013, Best practice & research. Clinical gastroenterology.

[41]  J. Olefsky,et al.  The cellular and signaling networks linking the immune system and metabolism in disease , 2012, Nature Medicine.

[42]  E. Zoetendal,et al.  Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats. , 2011, Environmental microbiology.

[43]  Jacques Schrenzel,et al.  Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice , 2011, Diabetes.

[44]  Jonathan Krakoff,et al.  Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. , 2011, The American journal of clinical nutrition.

[45]  L. Hoyles,et al.  Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. , 2010, Microbiology.

[46]  W. D. de Vos,et al.  Mucin-bacterial interactions in the human oral cavity and digestive tract , 2010, Gut microbes.

[47]  W. Cefalu,et al.  Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice , 2009, Diabetes.

[48]  J. Gordon,et al.  Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. , 2008, Cell host & microbe.

[49]  Masashi Yanagisawa,et al.  Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41 , 2008, Proceedings of the National Academy of Sciences.

[50]  W. D. de Vos,et al.  Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. , 2004, International journal of systematic and evolutionary microbiology.

[51]  K. Julge,et al.  Allergy development and the intestinal microflora during the first year of life. , 2001, The Journal of allergy and clinical immunology.

[52]  J. Harel,et al.  Virulence factors associated with F165-positive Escherichia coli strains isolated from piglets and calves. , 1993, Veterinary microbiology.

[53]  Weiqing Wang,et al.  Akkermansia muciniphila improves metabolic profiles by reducing inflammation in chow diet-fed mice. , 2017, Journal of molecular endocrinology.

[54]  W. Willett,et al.  Global obesity: trends, risk factors and policy implications , 2013, Nature Reviews Endocrinology.